CBG
Cannabigerol

How it occurs

Derived from CBGA, an important biosynthetic precursor to several major cannabinoid pathways.

Relationship to other cannabinoids

Neutral product of CBGA and part of a separate cannabinoid branch.

What is established

CBG occurs naturally, usually in relatively small amounts, and is pharmacologically active in laboratory studies.

Commonly reported effects

Energy, focus, digestive, and comfort claims are commonly marketed but remain preliminary.

Anecdotal or marketing-led unless stated otherwise

What remains uncertain

Human clinical research remains limited; retail claims frequently run ahead of evidence.

Evidence quality

Primarily laboratory and early human evidence.

Safety and potential interactions

Reliable interaction, pregnancy, and long-term safety data are limited.

Vaporization relevance

Heating can change cannabinoid form and delivery, but laboratory boiling points do not define a universal device setting. Heater design, sensor position, airflow, material, load, and draw behavior all affect exposure. This entry makes no compound-specific temperature recommendation.

Legal and regulatory context

Rules depend on product source, THC content, claims, and jurisdiction.

Dated source foundation

Direct authoritative sources reviewed 2026-08-20. These sources support the safety and regulatory boundaries of this draft; a scientific editor must still verify compound-specific claims against current peer-reviewed literature.

• FDA — Cannabis and cannabis-derived products: questions and answers ↗
• FDA — What to know about cannabis and CBD products ↗
• NIDA — Cannabis (Marijuana) ↗
• CDC — Cannabis frequently asked questions ↗

Related entries

CBGA · CBC

← All encyclopedia entries